nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGIR—hypertension	0.421	1	CbGaD
Alprostadil—SLCO2A1—Furosemide—hypertension	0.0971	0.394	CbGbCtD
Alprostadil—ABCC5—Atorvastatin—hypertension	0.0597	0.243	CbGbCtD
Alprostadil—SLCO2B1—Atorvastatin—hypertension	0.0376	0.153	CbGbCtD
Alprostadil—ABCC4—Atorvastatin—hypertension	0.0287	0.117	CbGbCtD
Alprostadil—ABCC4—Verapamil—hypertension	0.0232	0.0941	CbGbCtD
Alprostadil—PTGIR—pulmonary artery—hypertension	0.00505	0.111	CbGeAlD
Alprostadil—SLCO3A1—nephron—hypertension	0.00296	0.0651	CbGeAlD
Alprostadil—PTGIR—artery—hypertension	0.00187	0.0412	CbGeAlD
Alprostadil—PTGIR—endothelium—hypertension	0.00158	0.0348	CbGeAlD
Alprostadil—PTGIR—blood vessel—hypertension	0.00146	0.0321	CbGeAlD
Alprostadil—Epoprostenol—PTGIS—hypertension	0.00129	0.289	CrCbGaD
Alprostadil—PTGER2—adrenal cortex—hypertension	0.00122	0.0268	CbGeAlD
Alprostadil—PTGER2—decidua—hypertension	0.00114	0.0252	CbGeAlD
Alprostadil—Ethanolamine Oleate—F12—hypertension	0.00111	0.25	CrCbGaD
Alprostadil—PTGER1—kidney—hypertension	0.00103	0.0227	CbGeAlD
Alprostadil—SLCO3A1—cardiac ventricle—hypertension	0.000927	0.0204	CbGeAlD
Alprostadil—SLCO2A1—cardiac ventricle—hypertension	0.000918	0.0202	CbGeAlD
Alprostadil—PTGER2—adrenal gland—hypertension	0.000878	0.0193	CbGeAlD
Alprostadil—SLCO3A1—myocardium—hypertension	0.000872	0.0192	CbGeAlD
Alprostadil—SLCO2A1—myocardium—hypertension	0.000863	0.019	CbGeAlD
Alprostadil—ABCC5—cardiac ventricle—hypertension	0.000839	0.0185	CbGeAlD
Alprostadil—Epoprostenol—PTGIR—hypertension	0.000829	0.186	CrCbGaD
Alprostadil—PTGIR—brainstem—hypertension	0.000797	0.0175	CbGeAlD
Alprostadil—ABCC5—myocardium—hypertension	0.00079	0.0174	CbGeAlD
Alprostadil—PTGER1—endocrine gland—hypertension	0.000722	0.0159	CbGeAlD
Alprostadil—PTGIR—heart—hypertension	0.000689	0.0152	CbGeAlD
Alprostadil—PTGIR—smooth muscle tissue—hypertension	0.000684	0.015	CbGeAlD
Alprostadil—PTGER1—central nervous system—hypertension	0.000651	0.0143	CbGeAlD
Alprostadil—PTGIR—cardiovascular system—hypertension	0.00065	0.0143	CbGeAlD
Alprostadil—PTGIR—kidney—hypertension	0.000636	0.014	CbGeAlD
Alprostadil—SLCO2A1—nephron tubule—hypertension	0.000633	0.0139	CbGeAlD
Alprostadil—SLCO2A1—adrenal cortex—hypertension	0.000623	0.0137	CbGeAlD
Alprostadil—SLCO3A1—heart—hypertension	0.000608	0.0134	CbGeAlD
Alprostadil—SLCO2A1—heart—hypertension	0.000603	0.0133	CbGeAlD
Alprostadil—SLCO2A1—decidua—hypertension	0.000586	0.0129	CbGeAlD
Alprostadil—ABCC5—nephron tubule—hypertension	0.000579	0.0127	CbGeAlD
Alprostadil—SLCO3A1—kidney—hypertension	0.000562	0.0124	CbGeAlD
Alprostadil—SLCO2A1—kidney—hypertension	0.000556	0.0122	CbGeAlD
Alprostadil—ABCC5—heart—hypertension	0.000551	0.0121	CbGeAlD
Alprostadil—SLCO3A1—cortex of kidney—hypertension	0.000547	0.012	CbGeAlD
Alprostadil—SLCO2A1—cortex of kidney—hypertension	0.000542	0.0119	CbGeAlD
Alprostadil—ABCC5—decidua—hypertension	0.000536	0.0118	CbGeAlD
Alprostadil—SLCO3A1—cardiac atrium—hypertension	0.00052	0.0114	CbGeAlD
Alprostadil—SLCO2A1—cardiac atrium—hypertension	0.000515	0.0113	CbGeAlD
Alprostadil—PTGIR—adrenal gland—hypertension	0.000514	0.0113	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—hypertension	0.00049	0.0108	CbGeAlD
Alprostadil—ABCC5—cardiac atrium—hypertension	0.000471	0.0104	CbGeAlD
Alprostadil—Dinoprost Tromethamine—PTGIR—hypertension	0.000455	0.102	CrCbGaD
Alprostadil—SLCO3A1—adrenal gland—hypertension	0.000454	0.00999	CbGeAlD
Alprostadil—SLCO2A1—adrenal gland—hypertension	0.00045	0.00989	CbGeAlD
Alprostadil—PTGIR—endocrine gland—hypertension	0.000446	0.00982	CbGeAlD
Alprostadil—ABCC5—medulla oblongata—hypertension	0.000444	0.00978	CbGeAlD
Alprostadil—SLCO2B1—heart—hypertension	0.000431	0.00949	CbGeAlD
Alprostadil—SLCO2B1—decidua—hypertension	0.000419	0.00923	CbGeAlD
Alprostadil—ABCC5—adrenal gland—hypertension	0.000411	0.00905	CbGeAlD
Alprostadil—PTGIR—central nervous system—hypertension	0.000402	0.00885	CbGeAlD
Alprostadil—ABCC4—nephron tubule—hypertension	0.000401	0.00883	CbGeAlD
Alprostadil—SLCO2B1—kidney—hypertension	0.000398	0.00876	CbGeAlD
Alprostadil—SLCO3A1—endocrine gland—hypertension	0.000394	0.00866	CbGeAlD
Alprostadil—SLCO2A1—endocrine gland—hypertension	0.00039	0.00858	CbGeAlD
Alprostadil—ABCC4—heart—hypertension	0.000382	0.0084	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—hypertension	0.000355	0.00781	CbGeAlD
Alprostadil—ABCC4—kidney—hypertension	0.000353	0.00776	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—hypertension	0.000351	0.00773	CbGeAlD
Alprostadil—Dinoprostone—PTGIR—hypertension	0.00035	0.0786	CrCbGaD
Alprostadil—SLCO2B1—medulla oblongata—hypertension	0.000348	0.00765	CbGeAlD
Alprostadil—ABCC4—cortex of kidney—hypertension	0.000343	0.00756	CbGeAlD
Alprostadil—SLCO2B1—adrenal gland—hypertension	0.000322	0.00708	CbGeAlD
Alprostadil—ABCC4—adrenal gland—hypertension	0.000285	0.00627	CbGeAlD
Alprostadil—SLCO2B1—endocrine gland—hypertension	0.000279	0.00614	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—hypertension	0.000252	0.00553	CbGeAlD
Alprostadil—ABCC4—endocrine gland—hypertension	0.000247	0.00544	CbGeAlD
Alprostadil—ABCC4—central nervous system—hypertension	0.000223	0.0049	CbGeAlD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS1—hypertension	0.000143	0.0322	CrCbGaD
Alprostadil—Dinoprostone—CYP11A1—hypertension	0.000127	0.0286	CrCbGaD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—hypertension	8.19e-05	0.0184	CrCbGaD
Alprostadil—Dinoprostone—CYP19A1—hypertension	6.59e-05	0.0148	CrCbGaD
Alprostadil—Convulsion—Ramipril—hypertension	2.47e-05	0.00015	CcSEcCtD
Alprostadil—Dermatitis—Propranolol—hypertension	2.47e-05	0.00015	CcSEcCtD
Alprostadil—Body temperature increased—Trandolapril—hypertension	2.46e-05	0.000149	CcSEcCtD
Alprostadil—Abdominal pain—Trandolapril—hypertension	2.46e-05	0.000149	CcSEcCtD
Alprostadil—Diarrhoea—Verapamil—hypertension	2.46e-05	0.000149	CcSEcCtD
Alprostadil—Pain—Irbesartan—hypertension	2.46e-05	0.000149	CcSEcCtD
Alprostadil—Dizziness—Doxazosin—hypertension	2.45e-05	0.000149	CcSEcCtD
Alprostadil—Abdominal pain—Enalapril—hypertension	2.45e-05	0.000149	CcSEcCtD
Alprostadil—Body temperature increased—Enalapril—hypertension	2.45e-05	0.000149	CcSEcCtD
Alprostadil—Feeling abnormal—Captopril—hypertension	2.45e-05	0.000149	CcSEcCtD
Alprostadil—Dyspepsia—Betaxolol—hypertension	2.45e-05	0.000148	CcSEcCtD
Alprostadil—Loss of consciousness—Timolol—hypertension	2.45e-05	0.000148	CcSEcCtD
Alprostadil—Pain—Hydrochlorothiazide—hypertension	2.44e-05	0.000148	CcSEcCtD
Alprostadil—Cough—Timolol—hypertension	2.43e-05	0.000147	CcSEcCtD
Alprostadil—Dizziness—Fosinopril—hypertension	2.42e-05	0.000147	CcSEcCtD
Alprostadil—Abdominal pain—Telmisartan—hypertension	2.42e-05	0.000147	CcSEcCtD
Alprostadil—Body temperature increased—Telmisartan—hypertension	2.42e-05	0.000147	CcSEcCtD
Alprostadil—Dizziness—Eplerenone—hypertension	2.41e-05	0.000146	CcSEcCtD
Alprostadil—Asthenia—Valsartan—hypertension	2.41e-05	0.000146	CcSEcCtD
Alprostadil—Hypertension—Timolol—hypertension	2.41e-05	0.000146	CcSEcCtD
Alprostadil—Pain—Furosemide—hypertension	2.4e-05	0.000146	CcSEcCtD
Alprostadil—Discomfort—Ramipril—hypertension	2.4e-05	0.000145	CcSEcCtD
Alprostadil—Asthenia—Olmesartan—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Dizziness—Nifedipine—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Rash—Indapamide—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Rash—Diltiazem—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Anaemia—Lisinopril—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Dermatitis—Diltiazem—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Dermatitis—Indapamide—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Dyspepsia—Losartan—hypertension	2.39e-05	0.000145	CcSEcCtD
Alprostadil—Feeling abnormal—Perindopril—hypertension	2.38e-05	0.000144	CcSEcCtD
Alprostadil—Dizziness—Verapamil—hypertension	2.38e-05	0.000144	CcSEcCtD
Alprostadil—Pain—Betaxolol—hypertension	2.38e-05	0.000144	CcSEcCtD
Alprostadil—Feeling abnormal—Irbesartan—hypertension	2.38e-05	0.000144	CcSEcCtD
Alprostadil—Headache—Diltiazem—hypertension	2.37e-05	0.000144	CcSEcCtD
Alprostadil—Headache—Indapamide—hypertension	2.37e-05	0.000144	CcSEcCtD
Alprostadil—Pruritus—Valsartan—hypertension	2.37e-05	0.000144	CcSEcCtD
Alprostadil—Dry mouth—Ramipril—hypertension	2.37e-05	0.000144	CcSEcCtD
Alprostadil—Rash—Carvedilol—hypertension	2.37e-05	0.000143	CcSEcCtD
Alprostadil—Dermatitis—Carvedilol—hypertension	2.36e-05	0.000143	CcSEcCtD
Alprostadil—Pruritus—Olmesartan—hypertension	2.36e-05	0.000143	CcSEcCtD
Alprostadil—Feeling abnormal—Hydrochlorothiazide—hypertension	2.36e-05	0.000143	CcSEcCtD
Alprostadil—Abdominal pain—Captopril—hypertension	2.35e-05	0.000143	CcSEcCtD
Alprostadil—Body temperature increased—Captopril—hypertension	2.35e-05	0.000143	CcSEcCtD
Alprostadil—Headache—Carvedilol—hypertension	2.35e-05	0.000143	CcSEcCtD
Alprostadil—Discomfort—Timolol—hypertension	2.34e-05	0.000142	CcSEcCtD
Alprostadil—Rash—Doxazosin—hypertension	2.34e-05	0.000142	CcSEcCtD
Alprostadil—Dermatitis—Doxazosin—hypertension	2.34e-05	0.000142	CcSEcCtD
Alprostadil—Nausea—Propranolol—hypertension	2.33e-05	0.000141	CcSEcCtD
Alprostadil—Oedema—Ramipril—hypertension	2.33e-05	0.000141	CcSEcCtD
Alprostadil—Headache—Doxazosin—hypertension	2.33e-05	0.000141	CcSEcCtD
Alprostadil—Dry mouth—Timolol—hypertension	2.32e-05	0.000141	CcSEcCtD
Alprostadil—Pain—Losartan—hypertension	2.32e-05	0.000141	CcSEcCtD
Alprostadil—Syncope—Lisinopril—hypertension	2.32e-05	0.00014	CcSEcCtD
Alprostadil—Feeling abnormal—Furosemide—hypertension	2.32e-05	0.00014	CcSEcCtD
Alprostadil—Rash—Fosinopril—hypertension	2.31e-05	0.00014	CcSEcCtD
Alprostadil—Dermatitis—Fosinopril—hypertension	2.31e-05	0.00014	CcSEcCtD
Alprostadil—Rash—Eplerenone—hypertension	2.3e-05	0.000139	CcSEcCtD
Alprostadil—Headache—Fosinopril—hypertension	2.3e-05	0.000139	CcSEcCtD
Alprostadil—Dermatitis—Eplerenone—hypertension	2.3e-05	0.000139	CcSEcCtD
Alprostadil—Diarrhoea—Valsartan—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Asthenia—Clonidine—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Feeling abnormal—Betaxolol—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Shock—Ramipril—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Body temperature increased—Perindopril—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Abdominal pain—Perindopril—hypertension	2.29e-05	0.000139	CcSEcCtD
Alprostadil—Diarrhoea—Olmesartan—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Headache—Eplerenone—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Rash—Nifedipine—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Dermatitis—Nifedipine—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Abdominal pain—Irbesartan—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Body temperature increased—Irbesartan—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Thrombocytopenia—Ramipril—hypertension	2.28e-05	0.000138	CcSEcCtD
Alprostadil—Oedema—Timolol—hypertension	2.27e-05	0.000138	CcSEcCtD
Alprostadil—Loss of consciousness—Lisinopril—hypertension	2.27e-05	0.000138	CcSEcCtD
Alprostadil—Rash—Verapamil—hypertension	2.27e-05	0.000138	CcSEcCtD
Alprostadil—Tachycardia—Ramipril—hypertension	2.27e-05	0.000138	CcSEcCtD
Alprostadil—Dermatitis—Verapamil—hypertension	2.27e-05	0.000138	CcSEcCtD
Alprostadil—Headache—Nifedipine—hypertension	2.27e-05	0.000137	CcSEcCtD
Alprostadil—Pruritus—Clonidine—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Abdominal pain—Hydrochlorothiazide—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Body temperature increased—Hydrochlorothiazide—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Skin disorder—Ramipril—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Infection—Timolol—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Headache—Verapamil—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Cough—Lisinopril—hypertension	2.26e-05	0.000137	CcSEcCtD
Alprostadil—Nausea—Diltiazem—hypertension	2.25e-05	0.000136	CcSEcCtD
Alprostadil—Nausea—Indapamide—hypertension	2.25e-05	0.000136	CcSEcCtD
Alprostadil—Hyperhidrosis—Ramipril—hypertension	2.25e-05	0.000136	CcSEcCtD
Alprostadil—Asthenia—Trandolapril—hypertension	2.24e-05	0.000136	CcSEcCtD
Alprostadil—Shock—Timolol—hypertension	2.24e-05	0.000136	CcSEcCtD
Alprostadil—Feeling abnormal—Losartan—hypertension	2.24e-05	0.000135	CcSEcCtD
Alprostadil—Nausea—Carvedilol—hypertension	2.23e-05	0.000135	CcSEcCtD
Alprostadil—Asthenia—Enalapril—hypertension	2.23e-05	0.000135	CcSEcCtD
Alprostadil—Abdominal pain—Furosemide—hypertension	2.22e-05	0.000135	CcSEcCtD
Alprostadil—Body temperature increased—Furosemide—hypertension	2.22e-05	0.000135	CcSEcCtD
Alprostadil—Dizziness—Valsartan—hypertension	2.22e-05	0.000134	CcSEcCtD
Alprostadil—Skin disorder—Timolol—hypertension	2.21e-05	0.000134	CcSEcCtD
Alprostadil—Dizziness—Olmesartan—hypertension	2.21e-05	0.000134	CcSEcCtD
Alprostadil—Pruritus—Trandolapril—hypertension	2.21e-05	0.000134	CcSEcCtD
Alprostadil—Nausea—Doxazosin—hypertension	2.21e-05	0.000134	CcSEcCtD
Alprostadil—Body temperature increased—Betaxolol—hypertension	2.2e-05	0.000133	CcSEcCtD
Alprostadil—Hyperhidrosis—Timolol—hypertension	2.2e-05	0.000133	CcSEcCtD
Alprostadil—Asthenia—Telmisartan—hypertension	2.2e-05	0.000133	CcSEcCtD
Alprostadil—Pruritus—Enalapril—hypertension	2.2e-05	0.000133	CcSEcCtD
Alprostadil—Diarrhoea—Clonidine—hypertension	2.19e-05	0.000133	CcSEcCtD
Alprostadil—Nausea—Fosinopril—hypertension	2.18e-05	0.000132	CcSEcCtD
Alprostadil—Discomfort—Lisinopril—hypertension	2.17e-05	0.000132	CcSEcCtD
Alprostadil—Hypotension—Ramipril—hypertension	2.17e-05	0.000132	CcSEcCtD
Alprostadil—Pruritus—Telmisartan—hypertension	2.17e-05	0.000131	CcSEcCtD
Alprostadil—Nausea—Eplerenone—hypertension	2.17e-05	0.000131	CcSEcCtD
Alprostadil—Dry mouth—Lisinopril—hypertension	2.15e-05	0.00013	CcSEcCtD
Alprostadil—Nausea—Nifedipine—hypertension	2.15e-05	0.00013	CcSEcCtD
Alprostadil—Abdominal pain—Losartan—hypertension	2.14e-05	0.00013	CcSEcCtD
Alprostadil—Body temperature increased—Losartan—hypertension	2.14e-05	0.00013	CcSEcCtD
Alprostadil—Nausea—Verapamil—hypertension	2.14e-05	0.00013	CcSEcCtD
Alprostadil—Asthenia—Captopril—hypertension	2.14e-05	0.00013	CcSEcCtD
Alprostadil—Diarrhoea—Trandolapril—hypertension	2.13e-05	0.000129	CcSEcCtD
Alprostadil—Diarrhoea—Enalapril—hypertension	2.12e-05	0.000129	CcSEcCtD
Alprostadil—Hypotension—Timolol—hypertension	2.12e-05	0.000129	CcSEcCtD
Alprostadil—Rash—Valsartan—hypertension	2.11e-05	0.000128	CcSEcCtD
Alprostadil—Dizziness—Clonidine—hypertension	2.11e-05	0.000128	CcSEcCtD
Alprostadil—Dermatitis—Valsartan—hypertension	2.11e-05	0.000128	CcSEcCtD
Alprostadil—Oedema—Lisinopril—hypertension	2.11e-05	0.000128	CcSEcCtD
Alprostadil—Pruritus—Captopril—hypertension	2.11e-05	0.000128	CcSEcCtD
Alprostadil—Rash—Olmesartan—hypertension	2.1e-05	0.000128	CcSEcCtD
Alprostadil—Dermatitis—Olmesartan—hypertension	2.1e-05	0.000127	CcSEcCtD
Alprostadil—Headache—Valsartan—hypertension	2.1e-05	0.000127	CcSEcCtD
Alprostadil—Diarrhoea—Telmisartan—hypertension	2.1e-05	0.000127	CcSEcCtD
Alprostadil—Infection—Lisinopril—hypertension	2.1e-05	0.000127	CcSEcCtD
Alprostadil—Headache—Olmesartan—hypertension	2.09e-05	0.000127	CcSEcCtD
Alprostadil—Shock—Lisinopril—hypertension	2.08e-05	0.000126	CcSEcCtD
Alprostadil—Asthenia—Perindopril—hypertension	2.07e-05	0.000126	CcSEcCtD
Alprostadil—Asthenia—Irbesartan—hypertension	2.07e-05	0.000125	CcSEcCtD
Alprostadil—Thrombocytopenia—Lisinopril—hypertension	2.07e-05	0.000125	CcSEcCtD
Alprostadil—Dizziness—Trandolapril—hypertension	2.06e-05	0.000125	CcSEcCtD
Alprostadil—Tachycardia—Lisinopril—hypertension	2.06e-05	0.000125	CcSEcCtD
Alprostadil—Dizziness—Enalapril—hypertension	2.05e-05	0.000124	CcSEcCtD
Alprostadil—Asthenia—Hydrochlorothiazide—hypertension	2.05e-05	0.000124	CcSEcCtD
Alprostadil—Skin disorder—Lisinopril—hypertension	2.05e-05	0.000124	CcSEcCtD
Alprostadil—Dyspepsia—Ramipril—hypertension	2.05e-05	0.000124	CcSEcCtD
Alprostadil—Pruritus—Perindopril—hypertension	2.05e-05	0.000124	CcSEcCtD
Alprostadil—Pruritus—Irbesartan—hypertension	2.04e-05	0.000124	CcSEcCtD
Alprostadil—Hyperhidrosis—Lisinopril—hypertension	2.04e-05	0.000124	CcSEcCtD
Alprostadil—Diarrhoea—Captopril—hypertension	2.04e-05	0.000124	CcSEcCtD
Alprostadil—Dizziness—Telmisartan—hypertension	2.03e-05	0.000123	CcSEcCtD
Alprostadil—Pruritus—Hydrochlorothiazide—hypertension	2.02e-05	0.000123	CcSEcCtD
Alprostadil—Asthenia—Furosemide—hypertension	2.02e-05	0.000122	CcSEcCtD
Alprostadil—Rash—Clonidine—hypertension	2.02e-05	0.000122	CcSEcCtD
Alprostadil—Dermatitis—Clonidine—hypertension	2.01e-05	0.000122	CcSEcCtD
Alprostadil—Headache—Clonidine—hypertension	2e-05	0.000121	CcSEcCtD
Alprostadil—Dyspepsia—Timolol—hypertension	2e-05	0.000121	CcSEcCtD
Alprostadil—Asthenia—Betaxolol—hypertension	2e-05	0.000121	CcSEcCtD
Alprostadil—Nausea—Valsartan—hypertension	1.99e-05	0.000121	CcSEcCtD
Alprostadil—Pruritus—Furosemide—hypertension	1.99e-05	0.000121	CcSEcCtD
Alprostadil—Nausea—Olmesartan—hypertension	1.98e-05	0.00012	CcSEcCtD
Alprostadil—Diarrhoea—Perindopril—hypertension	1.98e-05	0.00012	CcSEcCtD
Alprostadil—Diarrhoea—Irbesartan—hypertension	1.97e-05	0.00012	CcSEcCtD
Alprostadil—Hypotension—Lisinopril—hypertension	1.97e-05	0.000119	CcSEcCtD
Alprostadil—Dizziness—Captopril—hypertension	1.97e-05	0.000119	CcSEcCtD
Alprostadil—Pruritus—Betaxolol—hypertension	1.97e-05	0.000119	CcSEcCtD
Alprostadil—Rash—Trandolapril—hypertension	1.97e-05	0.000119	CcSEcCtD
Alprostadil—Dermatitis—Trandolapril—hypertension	1.96e-05	0.000119	CcSEcCtD
Alprostadil—Rash—Enalapril—hypertension	1.96e-05	0.000119	CcSEcCtD
Alprostadil—Dermatitis—Enalapril—hypertension	1.96e-05	0.000119	CcSEcCtD
Alprostadil—Diarrhoea—Hydrochlorothiazide—hypertension	1.96e-05	0.000119	CcSEcCtD
Alprostadil—Headache—Trandolapril—hypertension	1.95e-05	0.000118	CcSEcCtD
Alprostadil—Asthenia—Losartan—hypertension	1.95e-05	0.000118	CcSEcCtD
Alprostadil—Headache—Enalapril—hypertension	1.95e-05	0.000118	CcSEcCtD
Alprostadil—Pain—Timolol—hypertension	1.94e-05	0.000118	CcSEcCtD
Alprostadil—Rash—Telmisartan—hypertension	1.93e-05	0.000117	CcSEcCtD
Alprostadil—Dermatitis—Telmisartan—hypertension	1.93e-05	0.000117	CcSEcCtD
Alprostadil—Diarrhoea—Furosemide—hypertension	1.92e-05	0.000117	CcSEcCtD
Alprostadil—Pruritus—Losartan—hypertension	1.92e-05	0.000116	CcSEcCtD
Alprostadil—Headache—Telmisartan—hypertension	1.92e-05	0.000116	CcSEcCtD
Alprostadil—Feeling abnormal—Ramipril—hypertension	1.92e-05	0.000116	CcSEcCtD
Alprostadil—Dizziness—Perindopril—hypertension	1.91e-05	0.000116	CcSEcCtD
Alprostadil—Dizziness—Irbesartan—hypertension	1.91e-05	0.000116	CcSEcCtD
Alprostadil—Diarrhoea—Betaxolol—hypertension	1.9e-05	0.000115	CcSEcCtD
Alprostadil—Nausea—Clonidine—hypertension	1.9e-05	0.000115	CcSEcCtD
Alprostadil—Dizziness—Hydrochlorothiazide—hypertension	1.89e-05	0.000115	CcSEcCtD
Alprostadil—Rash—Captopril—hypertension	1.88e-05	0.000114	CcSEcCtD
Alprostadil—Dermatitis—Captopril—hypertension	1.88e-05	0.000114	CcSEcCtD
Alprostadil—Feeling abnormal—Timolol—hypertension	1.87e-05	0.000114	CcSEcCtD
Alprostadil—Headache—Captopril—hypertension	1.87e-05	0.000113	CcSEcCtD
Alprostadil—Dizziness—Furosemide—hypertension	1.86e-05	0.000113	CcSEcCtD
Alprostadil—Dyspepsia—Lisinopril—hypertension	1.86e-05	0.000113	CcSEcCtD
Alprostadil—Diarrhoea—Losartan—hypertension	1.86e-05	0.000112	CcSEcCtD
Alprostadil—Nausea—Trandolapril—hypertension	1.85e-05	0.000112	CcSEcCtD
Alprostadil—Nausea—Enalapril—hypertension	1.84e-05	0.000112	CcSEcCtD
Alprostadil—Dizziness—Betaxolol—hypertension	1.84e-05	0.000112	CcSEcCtD
Alprostadil—Abdominal pain—Ramipril—hypertension	1.84e-05	0.000111	CcSEcCtD
Alprostadil—Body temperature increased—Ramipril—hypertension	1.84e-05	0.000111	CcSEcCtD
Alprostadil—Rash—Perindopril—hypertension	1.82e-05	0.000111	CcSEcCtD
Alprostadil—Dermatitis—Perindopril—hypertension	1.82e-05	0.00011	CcSEcCtD
Alprostadil—Nausea—Telmisartan—hypertension	1.82e-05	0.00011	CcSEcCtD
Alprostadil—Rash—Irbesartan—hypertension	1.82e-05	0.00011	CcSEcCtD
Alprostadil—Dermatitis—Irbesartan—hypertension	1.82e-05	0.00011	CcSEcCtD
Alprostadil—Headache—Perindopril—hypertension	1.81e-05	0.00011	CcSEcCtD
Alprostadil—Headache—Irbesartan—hypertension	1.81e-05	0.000109	CcSEcCtD
Alprostadil—Pain—Lisinopril—hypertension	1.8e-05	0.000109	CcSEcCtD
Alprostadil—Rash—Hydrochlorothiazide—hypertension	1.8e-05	0.000109	CcSEcCtD
Alprostadil—Dermatitis—Hydrochlorothiazide—hypertension	1.8e-05	0.000109	CcSEcCtD
Alprostadil—Body temperature increased—Timolol—hypertension	1.8e-05	0.000109	CcSEcCtD
Alprostadil—Abdominal pain—Timolol—hypertension	1.8e-05	0.000109	CcSEcCtD
Alprostadil—Dizziness—Losartan—hypertension	1.79e-05	0.000109	CcSEcCtD
Alprostadil—Headache—Hydrochlorothiazide—hypertension	1.79e-05	0.000109	CcSEcCtD
Alprostadil—Rash—Furosemide—hypertension	1.77e-05	0.000107	CcSEcCtD
Alprostadil—Dermatitis—Furosemide—hypertension	1.77e-05	0.000107	CcSEcCtD
Alprostadil—Nausea—Captopril—hypertension	1.77e-05	0.000107	CcSEcCtD
Alprostadil—Headache—Furosemide—hypertension	1.76e-05	0.000107	CcSEcCtD
Alprostadil—Rash—Betaxolol—hypertension	1.75e-05	0.000106	CcSEcCtD
Alprostadil—Dermatitis—Betaxolol—hypertension	1.75e-05	0.000106	CcSEcCtD
Alprostadil—Headache—Betaxolol—hypertension	1.74e-05	0.000106	CcSEcCtD
Alprostadil—Feeling abnormal—Lisinopril—hypertension	1.74e-05	0.000105	CcSEcCtD
Alprostadil—Nausea—Perindopril—hypertension	1.72e-05	0.000104	CcSEcCtD
Alprostadil—Nausea—Irbesartan—hypertension	1.71e-05	0.000104	CcSEcCtD
Alprostadil—Rash—Losartan—hypertension	1.71e-05	0.000104	CcSEcCtD
Alprostadil—Dermatitis—Losartan—hypertension	1.71e-05	0.000104	CcSEcCtD
Alprostadil—Headache—Losartan—hypertension	1.7e-05	0.000103	CcSEcCtD
Alprostadil—Nausea—Hydrochlorothiazide—hypertension	1.7e-05	0.000103	CcSEcCtD
Alprostadil—Nausea—Furosemide—hypertension	1.67e-05	0.000101	CcSEcCtD
Alprostadil—Asthenia—Ramipril—hypertension	1.67e-05	0.000101	CcSEcCtD
Alprostadil—Abdominal pain—Lisinopril—hypertension	1.67e-05	0.000101	CcSEcCtD
Alprostadil—Body temperature increased—Lisinopril—hypertension	1.67e-05	0.000101	CcSEcCtD
Alprostadil—Nausea—Betaxolol—hypertension	1.65e-05	0.0001	CcSEcCtD
Alprostadil—Pruritus—Ramipril—hypertension	1.65e-05	9.97e-05	CcSEcCtD
Alprostadil—Asthenia—Timolol—hypertension	1.63e-05	9.89e-05	CcSEcCtD
Alprostadil—Nausea—Losartan—hypertension	1.61e-05	9.76e-05	CcSEcCtD
Alprostadil—Pruritus—Timolol—hypertension	1.61e-05	9.75e-05	CcSEcCtD
Alprostadil—Diarrhoea—Ramipril—hypertension	1.59e-05	9.64e-05	CcSEcCtD
Alprostadil—Diarrhoea—Timolol—hypertension	1.56e-05	9.43e-05	CcSEcCtD
Alprostadil—Dizziness—Ramipril—hypertension	1.54e-05	9.32e-05	CcSEcCtD
Alprostadil—Asthenia—Lisinopril—hypertension	1.51e-05	9.17e-05	CcSEcCtD
Alprostadil—Dizziness—Timolol—hypertension	1.5e-05	9.11e-05	CcSEcCtD
Alprostadil—Pruritus—Lisinopril—hypertension	1.49e-05	9.04e-05	CcSEcCtD
Alprostadil—Rash—Ramipril—hypertension	1.47e-05	8.89e-05	CcSEcCtD
Alprostadil—Dermatitis—Ramipril—hypertension	1.47e-05	8.88e-05	CcSEcCtD
Alprostadil—Headache—Ramipril—hypertension	1.46e-05	8.83e-05	CcSEcCtD
Alprostadil—Diarrhoea—Lisinopril—hypertension	1.44e-05	8.75e-05	CcSEcCtD
Alprostadil—Rash—Timolol—hypertension	1.43e-05	8.69e-05	CcSEcCtD
Alprostadil—Dermatitis—Timolol—hypertension	1.43e-05	8.68e-05	CcSEcCtD
Alprostadil—Headache—Timolol—hypertension	1.42e-05	8.63e-05	CcSEcCtD
Alprostadil—Dizziness—Lisinopril—hypertension	1.39e-05	8.45e-05	CcSEcCtD
Alprostadil—Nausea—Ramipril—hypertension	1.38e-05	8.37e-05	CcSEcCtD
Alprostadil—Nausea—Timolol—hypertension	1.35e-05	8.19e-05	CcSEcCtD
Alprostadil—Rash—Lisinopril—hypertension	1.33e-05	8.06e-05	CcSEcCtD
Alprostadil—Dermatitis—Lisinopril—hypertension	1.33e-05	8.05e-05	CcSEcCtD
Alprostadil—Headache—Lisinopril—hypertension	1.32e-05	8.01e-05	CcSEcCtD
Alprostadil—Nausea—Lisinopril—hypertension	1.25e-05	7.59e-05	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—PRKCE—hypertension	5.37e-06	4.55e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—hypertension	5.34e-06	4.52e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRKCD—hypertension	5.34e-06	4.52e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GNB3—hypertension	5.33e-06	4.51e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARGC1A—hypertension	5.33e-06	4.51e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFA—hypertension	5.31e-06	4.49e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VAV3—hypertension	5.31e-06	4.49e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VAV3—hypertension	5.31e-06	4.49e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFA—hypertension	5.31e-06	4.49e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—hypertension	5.31e-06	4.49e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—RHOA—hypertension	5.26e-06	4.46e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAT—hypertension	5.23e-06	4.43e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFBR2—hypertension	5.23e-06	4.43e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFBR2—hypertension	5.23e-06	4.43e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—hypertension	5.22e-06	4.42e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3R1—hypertension	5.21e-06	4.41e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—hypertension	5.21e-06	4.41e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GNAS—hypertension	5.19e-06	4.4e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GNB3—hypertension	5.18e-06	4.39e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GNB3—hypertension	5.18e-06	4.39e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AVP—hypertension	5.11e-06	4.33e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AVP—hypertension	5.11e-06	4.33e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOB—hypertension	5.08e-06	4.3e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PDGFB—hypertension	5.08e-06	4.3e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RHOA—hypertension	5.07e-06	4.29e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RHOA—hypertension	5.07e-06	4.29e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR1—hypertension	5.05e-06	4.28e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GNAS—hypertension	5.05e-06	4.27e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GNAS—hypertension	5.05e-06	4.27e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—hypertension	5.03e-06	4.26e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3R1—hypertension	5.02e-06	4.25e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3R1—hypertension	5.02e-06	4.25e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INS—hypertension	5e-06	4.24e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HIF1A—hypertension	4.98e-06	4.21e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—hypertension	4.94e-06	4.19e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOB—hypertension	4.94e-06	4.19e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOB—hypertension	4.94e-06	4.19e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTK2—hypertension	4.92e-06	4.17e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTK2—hypertension	4.92e-06	4.17e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—hypertension	4.92e-06	4.17e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—hypertension	4.9e-06	4.15e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—hypertension	4.9e-06	4.15e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CALM1—hypertension	4.87e-06	4.13e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDN1—hypertension	4.86e-06	4.12e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDN1—hypertension	4.86e-06	4.12e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—hypertension	4.86e-06	4.11e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—LPL—hypertension	4.85e-06	4.11e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1—hypertension	4.84e-06	4.1e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT2—hypertension	4.83e-06	4.09e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL5—hypertension	4.83e-06	4.09e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL5—hypertension	4.83e-06	4.09e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EGFR—hypertension	4.81e-06	4.08e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CAV1—hypertension	4.81e-06	4.08e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOA1—hypertension	4.8e-06	4.07e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—hypertension	4.76e-06	4.03e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ADCY5—hypertension	4.75e-06	4.02e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPX1—hypertension	4.73e-06	4.01e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LPL—hypertension	4.72e-06	4e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LPL—hypertension	4.72e-06	4e-05	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—hypertension	4.71e-06	3.99e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PRKCA—hypertension	4.69e-06	3.97e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP1A1—hypertension	4.69e-06	3.97e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—H2AFX—hypertension	4.68e-06	3.97e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—H2AFX—hypertension	4.68e-06	3.97e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFRB—hypertension	4.68e-06	3.96e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFRB—hypertension	4.68e-06	3.96e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RPS6KB1—hypertension	4.68e-06	3.96e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RPS6KB1—hypertension	4.68e-06	3.96e-05	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—hypertension	4.65e-06	3.93e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADCY5—hypertension	4.62e-06	3.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADCY5—hypertension	4.62e-06	3.91e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CD36—hypertension	4.61e-06	3.9e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SERPINE1—hypertension	4.59e-06	3.89e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCG—hypertension	4.59e-06	3.89e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCG—hypertension	4.59e-06	3.89e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ITGB3—hypertension	4.56e-06	3.86e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCA—hypertension	4.56e-06	3.86e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ITGB3—hypertension	4.56e-06	3.86e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCA—hypertension	4.56e-06	3.86e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS2—hypertension	4.53e-06	3.83e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—YWHAZ—hypertension	4.52e-06	3.83e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—YWHAZ—hypertension	4.52e-06	3.83e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOTCH1—hypertension	4.48e-06	3.8e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—hypertension	4.47e-06	3.79e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SPP1—hypertension	4.47e-06	3.79e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—hypertension	4.47e-06	3.79e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SPP1—hypertension	4.47e-06	3.79e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—hypertension	4.45e-06	3.77e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—hypertension	4.45e-06	3.77e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF2—hypertension	4.45e-06	3.77e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RHOA—hypertension	4.43e-06	3.75e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3R1—hypertension	4.39e-06	3.72e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—hypertension	4.39e-06	3.72e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—hypertension	4.37e-06	3.7e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—hypertension	4.35e-06	3.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCD—hypertension	4.35e-06	3.68e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCD—hypertension	4.35e-06	3.68e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—hypertension	4.35e-06	3.68e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARA—hypertension	4.29e-06	3.63e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—hypertension	4.25e-06	3.6e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—hypertension	4.25e-06	3.6e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—C3—hypertension	4.25e-06	3.6e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—C3—hypertension	4.25e-06	3.6e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AGT—hypertension	4.15e-06	3.52e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—INS—hypertension	4.15e-06	3.51e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFB—hypertension	4.13e-06	3.5e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFB—hypertension	4.13e-06	3.5e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RELA—hypertension	4.13e-06	3.5e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR1—hypertension	4.11e-06	3.48e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR1—hypertension	4.11e-06	3.48e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CALM1—hypertension	4.08e-06	3.46e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—hypertension	4.07e-06	3.44e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HIF1A—hypertension	4.05e-06	3.43e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HIF1A—hypertension	4.05e-06	3.43e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MTOR—hypertension	4.05e-06	3.43e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AGT—hypertension	4.04e-06	3.42e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AGT—hypertension	4.04e-06	3.42e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAV1—hypertension	4.03e-06	3.41e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOA1—hypertension	4.02e-06	3.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—hypertension	4.02e-06	3.4e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT2—hypertension	4.01e-06	3.4e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CALM1—hypertension	3.97e-06	3.36e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CALM1—hypertension	3.97e-06	3.36e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—EP300—hypertension	3.96e-06	3.36e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LEP—hypertension	3.95e-06	3.35e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—hypertension	3.95e-06	3.35e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—hypertension	3.95e-06	3.35e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LEP—hypertension	3.95e-06	3.35e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CAV1—hypertension	3.92e-06	3.32e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CAV1—hypertension	3.92e-06	3.32e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOA1—hypertension	3.91e-06	3.31e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOA1—hypertension	3.91e-06	3.31e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—hypertension	3.89e-06	3.3e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KDR—hypertension	3.87e-06	3.28e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KDR—hypertension	3.87e-06	3.28e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SRC—hypertension	3.85e-06	3.26e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SERPINE1—hypertension	3.81e-06	3.23e-05	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—hypertension	3.76e-06	3.18e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—hypertension	3.75e-06	3.18e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCB—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCB—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FN1—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FN1—hypertension	3.73e-06	3.16e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—hypertension	3.7e-06	3.13e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF2—hypertension	3.69e-06	3.12e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RHOA—hypertension	3.68e-06	3.11e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH1—hypertension	3.65e-06	3.09e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH1—hypertension	3.65e-06	3.09e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—hypertension	3.64e-06	3.08e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3R1—hypertension	3.64e-06	3.08e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—hypertension	3.54e-06	3e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—hypertension	3.52e-06	2.98e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1A—hypertension	3.51e-06	2.97e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTEN—hypertension	3.5e-06	2.96e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—hypertension	3.49e-06	2.96e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—INS—hypertension	3.47e-06	2.94e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—hypertension	3.44e-06	2.92e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK8—hypertension	3.42e-06	2.9e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—hypertension	3.41e-06	2.89e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—hypertension	3.4e-06	2.88e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—hypertension	3.4e-06	2.88e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INS—hypertension	3.38e-06	2.86e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INS—hypertension	3.38e-06	2.86e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTOR—hypertension	3.36e-06	2.84e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EP300—hypertension	3.34e-06	2.83e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—hypertension	3.33e-06	2.82e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—hypertension	3.32e-06	2.82e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—hypertension	3.32e-06	2.82e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1—hypertension	3.27e-06	2.77e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1—hypertension	3.27e-06	2.77e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT2—hypertension	3.27e-06	2.77e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT2—hypertension	3.27e-06	2.77e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EGFR—hypertension	3.25e-06	2.75e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EGFR—hypertension	3.25e-06	2.75e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SRC—hypertension	3.24e-06	2.75e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—hypertension	3.19e-06	2.7e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—hypertension	3.16e-06	2.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SERPINE1—hypertension	3.1e-06	2.63e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SERPINE1—hypertension	3.1e-06	2.63e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—hypertension	3.05e-06	2.58e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3R1—hypertension	3.05e-06	2.58e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF2—hypertension	3e-06	2.54e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF2—hypertension	3e-06	2.54e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RHOA—hypertension	2.99e-06	2.54e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RHOA—hypertension	2.99e-06	2.54e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3R1—hypertension	2.96e-06	2.51e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—hypertension	2.96e-06	2.51e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—hypertension	2.96e-06	2.51e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3R1—hypertension	2.96e-06	2.51e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1A—hypertension	2.91e-06	2.46e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—hypertension	2.91e-06	2.46e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTEN—hypertension	2.9e-06	2.46e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—hypertension	2.9e-06	2.46e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGFR—hypertension	2.84e-06	2.41e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—hypertension	2.84e-06	2.4e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RELA—hypertension	2.79e-06	2.36e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RELA—hypertension	2.79e-06	2.36e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—hypertension	2.79e-06	2.36e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EP300—hypertension	2.77e-06	2.34e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MTOR—hypertension	2.73e-06	2.32e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MTOR—hypertension	2.73e-06	2.32e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SRC—hypertension	2.69e-06	2.28e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—hypertension	2.63e-06	2.23e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—hypertension	2.63e-06	2.23e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—hypertension	2.54e-06	2.15e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—hypertension	2.54e-06	2.15e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—hypertension	2.5e-06	2.12e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—hypertension	2.5e-06	2.12e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTEN—hypertension	2.43e-06	2.06e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—hypertension	2.41e-06	2.04e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—hypertension	2.41e-06	2.04e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—hypertension	2.39e-06	2.03e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—hypertension	2.39e-06	2.02e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—hypertension	2.38e-06	2.01e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—hypertension	2.38e-06	2.01e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1A—hypertension	2.37e-06	2.01e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1A—hypertension	2.37e-06	2.01e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTEN—hypertension	2.36e-06	2e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTEN—hypertension	2.36e-06	2e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGFR—hypertension	2.36e-06	2e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—EP300—hypertension	2.32e-06	1.96e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK8—hypertension	2.31e-06	1.96e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK8—hypertension	2.31e-06	1.96e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—hypertension	2.31e-06	1.95e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—hypertension	2.31e-06	1.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EP300—hypertension	2.25e-06	1.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EP300—hypertension	2.25e-06	1.91e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SRC—hypertension	2.19e-06	1.86e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SRC—hypertension	2.19e-06	1.86e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—hypertension	2.19e-06	1.85e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—hypertension	2.13e-06	1.81e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—hypertension	2.13e-06	1.81e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—hypertension	2.02e-06	1.71e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—hypertension	1.96e-06	1.66e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—hypertension	1.96e-06	1.66e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—hypertension	1.96e-06	1.66e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—hypertension	1.96e-06	1.66e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGFR—hypertension	1.92e-06	1.63e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGFR—hypertension	1.92e-06	1.63e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—hypertension	1.81e-06	1.54e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—hypertension	1.67e-06	1.42e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—hypertension	1.61e-06	1.37e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—hypertension	1.61e-06	1.37e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—hypertension	1.48e-06	1.25e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—hypertension	1.48e-06	1.25e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—hypertension	1.4e-06	1.19e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—hypertension	1.36e-06	1.15e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—hypertension	1.36e-06	1.15e-05	CbGpPWpGaD
